What question did this study set out to answer?

To assess the efficacy and safety of subthreshold micropulse laser treatment in acute central serous chorioretinopathy.

May 15, 2026BMC OphthalmologyOpen Access

Efficacy and safety of 577 nm subthreshold laser treatment in acute central serous chorioretinopathy

View Full Paper

Ask AI

Bookmark

To assess the efficacy and safety of subthreshold micropulse laser treatment in acute central serous chorioretinopathy.
Retrospective study of 46 eyes from 46 patients with acute CSC.
Twenty-five patients received SML treatment, 21 were observed without intervention.
Evaluated outcomes included BCVA, ONLT, SFCT, and SRF height.
BCVA improved significantly in the SML group (from 0.33 to 0.07 LogMAR, p < 0.001).
SFCT decreased significantly in the SML group (from 460.36 to 407.44 μm, p = 0.013).
Complete SRF resorption was achieved in all SML patients, compared to 23.8% in the observation group.

No takes yet. Share an insight, caveat, or question.

Retrospective trial assesses SML treatment efficacy in acute CSC, suggesting a promising management option.

Akçay et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark